Clinical Trial Update: A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety of INCA33890 in participants with advanced or metastatic solid tumors is currently recruiting, sponsored by Incyte Corpor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• INCA33890

Snippet

Sponsor: Incyte Corporation | Conditions: Solid Tumors, Advanced Solid Tumors | Phase 1 | Status: RECRUITING